BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17675253)

  • 1. Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.
    Fraisier C; Arnarson H; Barbezange C; Andrésdŏttir V; Carrozza ML; De Andrés D; Tolari F; Rosati S; Luján L; Pépin M; Amorena B; Harkiss G; Blacklaws B; Suzan-Monti M
    J Virol Methods; 2007 Dec; 146(1-2):363-7. PubMed ID: 17675253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans.
    Sánchez AB; Rodríguez D; Garzón A; Amorena B; Esteban M; Rodríguez JR
    Arch Virol; 2002 Dec; 147(12):2377-92. PubMed ID: 12491104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection.
    González B; Reina R; García I; Andrés S; Glaria I; Alzueta M; Mora MI; Jugo BM; Arrieta-Aguirre I; de la Lastra JM; Rodríguez D; Rodríguez JR; Esteban M; Grilló MJ; Blacklaws BA; Harkiss GD; Chebloune Y; Luján L; de Andrés D; Amorena B
    Vaccine; 2005 Jul; 23(34):4342-52. PubMed ID: 16005743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of transgenic sheep that express the visna virus envelope gene.
    Clements JE; Wall RJ; Narayan O; Hauer D; Schoborg R; Sheffer D; Powell A; Carruth LM; Zink MC; Rexroad CE
    Virology; 1994 May; 200(2):370-80. PubMed ID: 8178428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus.
    de Andrés X; Reina R; Ciriza J; Crespo H; Glaria I; Ramírez H; Grilló MJ; Pérez MM; Andrésdóttir V; Rosati S; Suzan-Monti M; Luján L; Blacklaws BA; Harkiss GD; de Andrés D; Amorena B
    Vaccine; 2009 Jul; 27(34):4591-600. PubMed ID: 19538997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a candidate DNA vaccine against Maedi-Visna virus.
    Henriques AM; Fevereiro M; Prazeres DM; Monteiro GA
    Vet Immunol Immunopathol; 2007 Oct; 119(3-4):222-32. PubMed ID: 17624445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes.
    Reina R; Barbezange C; Niesalla H; de Andrés X; Arnarson H; Biescas E; Mazzei M; Fraisier C; McNeilly TN; Liu C; Perez M; Carrozza ML; Bandecchi P; Solano C; Crespo H; Glaria I; Huard C; Shaw DJ; de Blas I; de Andrés D; Tolari F; Rosati S; Suzan-Monti M; Andrésdottir V; Torsteinsdottir S; Petursson G; Lujan L; Pepin M; Amorena B; Blacklaws B; Harkiss GD
    Vaccine; 2008 Aug; 26(35):4494-505. PubMed ID: 18606204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes.
    Niesalla H; de Andrés X; Barbezange C; Fraisier C; Reina R; Arnarson H; Biescas E; Mazzei M; McNeilly TN; Liu C; Watkins C; Perez M; Carrozza ML; Bandecchi P; Solano C; Crespo H; Glaria I; Huard C; Shaw DJ; de Blas I; de Andrés D; Tolari F; Rosati S; Suzan-Monti M; Andrésdottir V; Torsteinsdottir S; Petursson G; Badiola J; Lujan L; Pepin M; Amorena B; Blacklaws B; Harkiss GD
    Vaccine; 2009 Jan; 27(2):260-9. PubMed ID: 18984025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maedi-visna virus and its relationship to human immunodeficiency virus.
    Thormar H
    AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer systems derived from Visna virus: analysis of virus production and infectivity.
    Berkowitz RD; Ilves H; Plavec I; Veres G
    Virology; 2001 Jan; 279(1):116-29. PubMed ID: 11145895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum containing ovine IgG2 antibody specific for maedi visna virus envelope glycoprotein mediates antibody dependent cellular cytotoxicity.
    Singh I; McConnell I; Dalziel R; Blacklaws BA
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):357-66. PubMed ID: 16876878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cationic liposomes/DNA charge ratio on gene expression and antibody response of a candidate DNA vaccine against Maedi Visna virus.
    Henriques AM; Madeira C; Fevereiro M; Prazeres DM; Aires-Barros MR; Monteiro GA
    Int J Pharm; 2009 Jul; 377(1-2):92-8. PubMed ID: 19446620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for recombination in the envelope gene of maedi-visna virus.
    Andrésdóttir V
    Virus Genes; 2003 Aug; 27(1):5-9. PubMed ID: 12913353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maedi-visna virus infection in sheep: a review.
    Pépin M; Vitu C; Russo P; Mornex JF; Peterhans E
    Vet Res; 1998; 29(3-4):341-67. PubMed ID: 9689746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of sheep with Maedi-visna virus gag gene and protein, beneficial or harmful?
    Torsteinsdóttir S; Carlsdóttir HM; Svansson V; Matthíasdóttir S; Martin AH; Pétursson G
    Vaccine; 2007 Sep; 25(37-38):6713-20. PubMed ID: 17686553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to recombinant visna virus Gag and Env precursor proteins synthesized in insect cells.
    Rafnar B; Tobin GJ; Nagashima K; Gonda MA; Gunnarsson E; Andrésson OS; Georgsson G; Torsteinsdóttir S
    Virus Res; 1998 Feb; 53(2):107-20. PubMed ID: 9620203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
    Zheng Q; Li P; Cao R; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of wild-type, C-terminally truncated, and chimeric maedi-visna virus glycoprotein and putative pseudotyping of retroviral vector particles.
    Zeilfelder U; Bosch V
    J Virol; 2001 Jan; 75(1):548-55. PubMed ID: 11119626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination immunization with EIAV Env protein expressed by recombinant baculovirus and recombinant vaccinia virus containing env gene].
    Dai CM; Zhang XY; Zhang RR; Shao YM; Shen RX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):410-4. PubMed ID: 15207082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus.
    Andrésdóttir V; Tang X; Agnarsdóttir G; Andrésson OS; Georgsson G; Skraban R; Torsteinsdóttir S; Rafnar B; Benediktsdóttir E; Matthíasdóttir S; Arnadóttir S; Högnadóttir S; Pálsson PA; Pétursson G
    Virus Genes; 1998; 16(3):281-93. PubMed ID: 9654682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.